7/16/2018 12:16:08 PM - Slumped from its 52-week high and violated its 50 DMA line ($106.79). Noted with caution in prior mid-day reports - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
7/11/2018 1:09:50 PM - Still hovering near its 52-week high. Found support above prior highs and its 50 DMA line during its consolidation since noted with caution in the 6/19/18 mid-day report - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
7/9/2018 12:28:10 PM - Still hovering near its 52-week high, it found support above prior highs and its 50 DMA line during its consolidation since noted with caution in the 6/19/18 mid-day report - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
7/6/2018 12:29:08 PM - Hovering near its 52-week high, it found support above prior highs and its 50 DMA line during its consolidation since noted with caution in the 6/19/18 mid-day report - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
7/3/2018 11:39:05 AM - Hovering near its 52-week high, it found support above prior highs and its 50 DMA line during its consolidation since noted with caution in the 6/19/18 mid-day report - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
6/29/2018 12:27:18 PM - Hovering near its 52-week high, stubbornly holding its ground since noted in the 6/19/18 mid-day report - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
6/28/2018 12:20:53 PM - Hovering near its 52-week high, stubbornly holding its ground since last noted in the 6/19/18 mid-day report - "Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies."
6/19/2018 1:05:36 PM - Recently consolidated in a tight range above its 50 DMA line and today's 5th consecutive volume-driven gain has it hitting yet another new 52-week high. Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
6/15/2018 12:56:37 PM - Recently consolidating in a tight range above its 50 DMA line and today's 3rd consecutive volume-driven gain has it perched within striking distance of its 52-week high. Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
6/14/2018 1:04:46 PM - Still consolidating in a tight range above its 50 DMA line and perched within striking distance of its 52-week high. Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
6/13/2018 12:58:19 PM - Still consolidating in a tight range above its 50 DMA line and perched within striking distance of its 52-week high. Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
6/5/2018 1:02:46 PM - Found support while consolidating above its 50 DMA line and it is perched within striking distance of its 52-week high. Reported earnings +15% on +6% sales revenues for the Mar '18 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases were not strong and steady above the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
4/17/2018 1:14:13 PM - Wedged to new highs with more gains lacking great volume conviction. Found support while consolidating above its 50 DMA line. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
4/3/2018 12:50:12 PM - Wedged to new highs last week with more gains lacking great volume conviction. Found support while consolidating above its 50 DMA line. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
3/27/2018 1:14:35 PM - Wedging to new highs this week with more gains lacking great volume conviction. Found support while consolidating above its 50 DMA line. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
3/16/2018 1:15:07 PM - Wedging to new highs this week with gains lacking great volume conviction. Found support while consolidating above its 50 DMA line and prior highs in the $85 area. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
3/13/2018 12:59:57 PM - Quietly wedged to new highs this week. Found support while consolidating above its 50 DMA line and prior highs in the $85 area. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria). Quarterly sales revenues totals in the $9-11 million range are rather minuscule for publicly traded companies.
3/2/2018 1:02:25 PM - Consolidating above its 50 DMA line and prior highs defining near-term support in the $85 area. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
2/28/2018 1:14:37 PM - Consolidating near its all-time high. Its 50 DMA line and prior highs define near-term support in the $85 area. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
2/21/2018 1:03:35 PM - Consolidating near its all-time high. Its 50 DMA line and prior highs define near-term support in the $85 area. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
2/16/2018 12:37:57 PM - Rebounding near its all-time high with today's 3rd consecutive volume-driven gain while consolidating. Its 50 DMA line and prior highs define near-term support in the $85 area. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
2/14/2018 1:09:44 PM - Perched near its all-time high, consolidating above its 50 DMA line. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
2/6/2018 1:05:26 PM - Perched near its all-time high. Reported earnings +38% on +15% sales revenues for the Dec '17 quarter. Prior quarterly comparisons showed sub par sales revenues and earnings increases below the +25% minimum guideline (C criteria).
6/2/2016 12:43:37 PM - Perched near all-time highs, the 5/05/16 mid-day report last cautioned members - "Quarterly comparisons through Mar '16 show sub par sales revenues and earnings increases."
5/5/2016 12:49:51 PM - Quarterly comparisons through Mar '16 show sub par sales revenues and earnings increases. Perched at all-time highs.